M. Hammerschlag

M. Hammerschlag, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture.

T. Quinn, C. Gaydos, J. Schachter, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods.

M. Hammerschlag, Swati Kumar, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Therapeutic approaches to Chlamydia infections

Gilbert GREUB, L. Senn, M. Hammerschlag, 2005, Expert opinion on pharmacotherapy.

Overcoming Current Obstacles in the Management of Bacterial Community-Acquired Pneumonia in Ambulatory Children

S. Pelton, M. Hammerschlag, 2005, Clinical pediatrics.

Chlamydophila (Chlamydia) pneumoniae

P. Apfalter, S. Kohlhoff, M. Hammerschlag, 2010 .

Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis.

P. Apfalter, M. Hammerschlag, J. Boman, 2003, Stroke.

Community-Acquired Pneumonia Due To Atypical Organisms in Adults: Diagnosis and Treatment

M. Hammerschlag, 1999 .

Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection

M. Hammerschlag, U. Emre, P. Roblin, 1997, Clinical and diagnostic laboratory immunology.

Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis?

M. Hammerschlag, B. Kálmán, J. Boman, 2000, Journal of Clinical Microbiology.

The role of Chlamydia in upper respiratory tract infections

M. Hammerschlag, 2000, Current infectious disease reports.

Activity of Quinolones Against Chlamydia pneumoniae

M. Hammerschlag, 2012, Drugs.

Chlamydia pneumoniae and asthma and atherosclerosis: role of macrolides

M. Hammerschlag, 2002 .

Mycoplasma pneumoniae infections

M. Hammerschlag, 2001, Current opinion in infectious diseases.

Chlamydia pneumoniae and the lung.

M. Hammerschlag, 2000, The European respiratory journal.

Ultrastructural Study of Chlamydia pneumoniae In a Continuous-Infection Model

P. Timms, D. Stenzel, M. Hammerschlag, 2001, Journal of Clinical Microbiology.

Persistent infection with Chlamydia pneumoniae following acute respiratory illness.

Philip Smith, K. Chirgwin, J. Schachter, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The intracellular life of chlamydiae.

M. Hammerschlag, 2002, Seminars in pediatric infectious diseases.

The association of Chlamydia pneumoniae infection and reactive airway disease in children.

J. Schachter, M. Hammerschlag, U. Emre, 1994, Archives of pediatrics & adolescent medicine.

Chlamydia pneumoniae enhances the Th2 profile of stimulated peripheral blood mononuclear cells from asthmatic patients.

S. Kohlhoff, H. Durkin, T. Smith-Norowitz, 2016, Human immunology.

Prospective study of maternal and infantile infection with Chlamydia trachomatis.

M. Anderka, M. Hammerschlag, W. Mccormack, 1979, Pediatrics.

Colonization with group B streptococci in girls under 16 years of age.

D. Kasper, C. Baker, M. Hammerschlag, 1977, Pediatrics.

Treatment of chlamydial infections

S. Kohlhoff, M. Hammerschlag, 2012, Expert opinion on pharmacotherapy.

In Vitro Activity of a New 8-Methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, 1998, Antimicrobial Agents and Chemotherapy.

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections

M. Hammerschlag, Roopali Sharma, 2008 .

In Vitro Activity of ABT 773, a New Ketolide Antibiotic, against Chlamydia pneumoniae

M. Hammerschlag, S. Strigl, P. Roblin, 2000, Antimicrobial Agents and Chemotherapy.

Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, A. Kutlin, 1999, International journal of antimicrobial agents.

Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.

S. Kohlhoff, H. Durkin, T. Smith-Norowitz, 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Treatment of chlamydial infections: 2014 update

S. Kohlhoff, M. Hammerschlag, 2015, Expert opinion on pharmacotherapy.

Peritonitis Caused by Neisseria sicca in a Child on Chronic Peritoneal Dialysis

A. D'angelo, M. Hammerschlag, M. Schoeneman, 2007 .

Azithromycin decreases Chlamydia pneumoniae-mediated Interleukin-4 responses but not Immunoglobulin E responses

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2020, PloS one.

Increased seroprevalence of Enterovirus 71 IgE antibodies in asthmatic compared with non-asthmatic children

J. Weedon, S. Kohlhoff, K. Norowitz, 2017, Irish Journal of Medical Science (1971 -).

Epidemiology of sexually transmitted diseases in rape victims.

M. Hammerschlag, W. Mccormack, J. Glaser, 1989, Reviews of infectious diseases.

Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis

M. Hammerschlag, B. Kálmán, J. Boman, 2000, Annals of neurology.

In vitro models of acute and long-term continuous infection of human respiratory epithelial cells with Chlamydophila pneumoniae have opposing effects on host cell apoptosis.

S. Kohlhoff, M. Hammerschlag, Christopher A. J. Roman, 2008, Microbial pathogenesis.

Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections.

P. Timms, M. Hammerschlag, Richard J. Hogan, 2003, Microbial pathogenesis.

Are heart attacks infectious? A critical look at the link between Chlamydia pneumoniae and atherosclerosis

M. Hammerschlag, S. Weiss, 1997 .

Methicillin-resistant Staphylococcus aureus colonization in otitis-prone children.

Haidy A. Marzouk, N. Goldstein, J. Weedon, 2011, Archives of otolaryngology--head & neck surgery.

Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin

M. Hammerschlag, Roopali Sharma, 2019, Current Infectious Disease Reports.

Chlamydia pneumoniae in acute otitis media.

J. Hedrick, T. Quinn, C. Gaydos, 1997, The Pediatric Infectious Disease Journal.

Chlamydia pneumoniae infections.

M. Hammerschlag, 1993, The Pediatric Infectious Disease Journal.

Chlamydia pneumoniae infection in patients with cystic fibrosis.

J. Summersgill, J. Schachter, M. Hammerschlag, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chlamydia pneumoniae A new respiratory pathogen

M. Hammerschlag, 1992 .

Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture.

M. Augenbraun, J. Schachter, M. Hammerschlag, 1991, The American journal of medicine.

The role of Chlamydia trachomatis in middle ear effusions in children.

M. Hammerschlag, E. Alexander, P. Hammerschlag, 1980, Pediatrics.

Pneumonia due to Chlamydia pneumoniae in children: Epidemiology, diagnosis, and treatment

M. Hammerschlag, 2003, Pediatric pulmonology.

Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection.

M. Hammerschlag, 2002, Circulation.

Current status of laboratory diagnosis of Chlamydia pneumoniae and Chlamydia psittaci

M. Hammerschlag, 2001 .

Current Status of Laboratory Diagnosis of Chlamydia pneumoniaa

M. Hammerschlag, 2001 .

More on Chlamydia pneumonia and meningoencephalitis.

M. Hammerschlag, S. Weiss, P. Roblin, 1995, The New England journal of medicine.

Chlamydia pneumoniae induces interleukin-12 responses in peripheral blood mononuclear cells in asthma and the role of toll like receptor 2 versus 4: a pilot study

S. Kohlhoff, H. Durkin, T. Smith-Norowitz, 2017, Irish Journal of Medical Science (1971 -).

Antibody response to Chlamydia pneumoniae infection in children with respiratory illness.

M. Hammerschlag, P. Roblin, A. Kutlin, 1998, The Journal of infectious diseases.

Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia

M. Hammerschlag, P. Roblin, G. Montalban, 1994, Antimicrobial Agents and Chemotherapy.

In vitro activities of five quinolones against Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, C. L. Hyman, 1992, Antimicrobial Agents and Chemotherapy.

Infection with Simkania negevensis in Brooklyn, New York

S. Kohlhoff, M. Hammerschlag, S. Kahane, 2005, The Pediatric infectious disease journal.

Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki disease.

A. Rowley, M. Hammerschlag, J. Boman, 2001, The Pediatric infectious disease journal.

Is there an association between Kawasaki disease and Chlamydia pneumoniae?

S. Shulman, M. Hammerschlag, S. Strigl, 2000, The Journal of infectious diseases.

Immunopathogenesis of Chlamydia pneumoniae Infections in Children

M. Hammerschlag, 1996, Infectious diseases in obstetrics and gynecology.

Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro

M. Hammerschlag, U. Emre, P. Roblin, 1996, Journal of clinical microbiology.

Treatment options for neonatal infections in the post-cefotaxime era

M. Hammerschlag, Susannah Franco, Daniel Rampersad, 2022, Expert review of anti-infective therapy.

Herpes zoster in an adult recipient of live attenuated varicella vaccine.

A. Gershon, S. Steinberg, M. Hammerschlag, 1989, The Journal of infectious diseases.

Immunization of healthy adults with live attenuated varicella vaccine.

P. LaRussa, A. Gershon, S. Steinberg, 1988, The Journal of infectious diseases.

Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis

M. Hammerschlag, I. Delke, P. Roblin, 1989, The New England journal of medicine.

IMMUNE RESPONSE AFTER SPLENECTOMY

E. Vichinsky, J. Miser, J. Sullivan, 1978, The Lancet.

Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus

M. Augenbraun, K. Chirgwin, D. Landman, 1991, Journal of Clinical Microbiology.

Coronavirus disease 2019 prevalence rates in reopened private schools in New York City: Impact of diagnostic methods

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2021, Acta paediatrica.

In Vitro Activity of Omadacycline against Chlamydia pneumoniae

S. Kohlhoff, M. Hammerschlag, N. Huerta, 2018, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae

M. Huband, S. Kohlhoff, M. Hammerschlag, 2014, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia 1

M. Huband, S. Kohlhoff, M. Hammerschlag, 2014 .

In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae

S. Kohlhoff, M. Hammerschlag, K. Chotikanatis, 2013, Antimicrobial Agents and Chemotherapy.

Isolation and Antimicrobial Susceptibilities of Chlamydial Isolates from Western Barred Bandicoots (cid:1)

P. Timms, S. Kohlhoff, M. Hammerschlag, 2007 .

Isolation and Antimicrobial Susceptibilities of Chlamydial Isolates from Western Barred Bandicoots

P. Timms, S. Kohlhoff, M. Hammerschlag, 2006, Journal of Clinical Microbiology.

The role of Chlamydia pneumoniae infection in children with chronic sinusitis.

N. Goldstein, Anthony Cultrara, M. Hammerschlag, 2003, Archives of otolaryngology--head & neck surgery.

Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, 2000, International journal of antimicrobial agents.

State of the art in the diagnosis of acute and chronic Chlamydia pneumoniae infection

M. Hammerschlag, 2000 .

In Vitro Activities of Gemifloxacin (SB 265805, LB20304) against Recent Clinical Isolates of Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, A. Kutlin, 1999, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Azithromycin and Ofloxacin againstChlamydia pneumoniae in a Continuous-Infection Model

M. Hammerschlag, P. Roblin, A. Kutlin, 1999, Antimicrobial Agents and Chemotherapy.

Chlamydia pneumoniae: How to Document Respiratory Infection

M. Hammerschlag, 1999 .

How to Document Respiratory Infection

M. Hammerschlag, 1999 .

Microbiologic Efficacy of Azithromycin and Susceptibilities to Azithromycin of Isolates of Chlamydia pneumoniae from Adults and Children with Community-Acquired Pneumonia

M. Hammerschlag, P. Roblin, 1998, Antimicrobial Agents and Chemotherapy.

Diagnosis of chlamydial infection in the pediatric population.

M. Hammerschlag, 1997, Immunological investigations.

Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture

M. Hammerschlag, P. Roblin, G. Montalban, 1994, Journal of clinical microbiology.

Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.

M. Hammerschlag, P. Roblin, G. Montalban, 1995, Antimicrobial agents and chemotherapy.

Current knowledge ofChlamydia pneumoniae and atherosclerosis

M. Hammerschlag, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Chlamydia pneumoniae and atherosclerosis: what we know and what we don't know.

M. Hammerschlag, 2000, The Pediatric infectious disease journal.

In-vitro activity of dirithromycin against Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, A. Kutlin, 1997, The Journal of antimicrobial chemotherapy.

Chlamydia trachomatis selectively stimulates myeloperoxidase release but not superoxide production by human neutrophils.

M. Hammerschlag, M. Tosi, 1988, The Journal of infectious diseases.

Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents.

M. Hammerschlag, 2004, Pediatrics in review.

Management of Bone and Joint Infections in Children: Recent Experience at an Urban Medical Center

S. Kohlhoff, M. Hammerschlag, Rita Nathawad, 2012 .

Asymptomatic respiratory infection with Chlamydia pneumoniae : what does it mean?

M. Hammerschlag, 2001, Chest.

Comparison of an Industry-Derived LCx Chlamydia pneumoniae PCR Research Kit to In-House Assays Performed in Five Laboratories

C. Gaydos, J. Summersgill, M. Smieja, 2002, Journal of Clinical Microbiology.

The effect of Chlamydia trachomatis on luminol-dependent chemiluminescence of human polymorphonuclear leukocytes: requirements for opsonization.

M. Hammerschlag, K. Suntharalingam, S. Fikrig, 1985, The Journal of infectious diseases.

If We Make It, Will They Take It? Attitudes Toward the Acceptability of Chlamydia Point-of-Care Testing Among Adolescents and Young Adults

M. Hammerschlag, A. Suss, P. Pastolero, 2021, Sexually transmitted diseases.

Reply to Don et al

S. Kohlhoff, M. Hammerschlag, S. Kahane, 2006 .

Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease.

K. Chirgwin, J. Schachter, S. Miller, 1991, The Journal of pediatrics.

Pediatric Fistula Initiative: Reducing Bloodstream Infections in an Outpatient Pediatric Hemodialysis Center.

S. Kohlhoff, M. Hammerschlag, M. Schoeneman, 2015, Journal of the Pediatric Infectious Diseases Society.

Prevalence of Chlamydia trachomatis cervical infection in female adolescents.

N. Golden, M. Hammerschlag, S. Neuhoff, 1984, American journal of diseases of children.

Longitudinal studies on chlamydial infections in the first year of life

L. Koutsky, M. Hammerschlag, J. Chandler, 1982, Pediatric infectious disease.

Cerebrospinal fluid rhinorrhea and recurrent meningitis.

M. Hammerschlag, P. Hammerschlag, D. Pappas, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chlamydia trachomatis in children.

M. Hammerschlag, 1994, Pediatric annals.

Meningococcal bacteremia: clinical and serologic studies of infants with mild illness.

R. Baltimore, M. Hammerschlag, 1977, American journal of diseases of children.

Coronavirus disease 2019 (COVID‐19) infection rates in a private school in Brooklyn, New York

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2021, Acta paediatrica.

In vitro activity of trovafloxacin against Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, A. Kutlin, 1997, Antimicrobial agents and chemotherapy.

Chlamydial and gonococcal infections in infants and children.

M. Hammerschlag, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Activities of BMS-284756 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, A. Kutlin, 2002, Antimicrobial Agents and Chemotherapy.

In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, 1999, The Journal of antimicrobial chemotherapy.

Cryptococcal Osteomyelitis

M. Hammerschlag, J. Haller, J. Domingo, 1982, Clinical pediatrics.

In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis

M. Hammerschlag, A. Gleyzer, 1983, Antimicrobial Agents and Chemotherapy.

Doxycycline suppresses Chlamydia pneumoniae-mediated increases in ongoing immunoglobulin E and interleukin-4 responses by peripheral blood mononuclear cells of patients with allergic asthma.

S. Kohlhoff, H. Durkin, T. Smith-Norowitz, 2013, The Journal of antimicrobial chemotherapy.

Minocycline treatment results in reduced oral steroid requirements in adult asthma.

M. Hammerschlag, R. Joks, M. Gelling, 2008, Allergy and asthma proceedings.

Recurrent Intravascular-Catheter-Related Bacteremia Caused by Delftia acidovorans in a Hemodialysis Patient

M. Hammerschlag, K. Chotikanatis, M. Bäcker, 2011, Journal of Clinical Microbiology.

Microbiology of the vagina in children: normal and potentially pathogenic organisms.

M. Hammerschlag, W. Mccormack, S. Alpert, 1978, Pediatrics.

SARS-CoV-2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth

Mimi Y. Kim, M. Cabana, J. Aschner, 2020, The Journal of Pediatrics.

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.

M. Campbell, G. Cassell, M. Hammerschlag, 1998, The Pediatric infectious disease journal.

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

R. Peeling, S. Dowell, J. Guarner, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection.

D. Eschenbach, L. Koutsky, M. Hammerschlag, 1980, JAMA.

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.

M. Hammerschlag, M R Hammerschlag, 2001, The Journal of antimicrobial chemotherapy.

Molecular characterization of Chlamydophila pneumoniae isolates from Western barred bandicoots.

P. Timms, S. Kohlhoff, M. Hammerschlag, 2007, Journal of medical microbiology.

Emergence of Resistance to Rifampin and Rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis

S. Kohlhoff, M. Hammerschlag, P. Riska, 2005, Antimicrobial Agents and Chemotherapy.

Comparison of Kodak Surecell Chlamydia Test Kit with culture for the diagnosis of chlamydial conjunctivitis in infants

M. Hammerschlag, M. Gelling, P. Roblin, 1990, Journal of clinical microbiology.

Medical and Legal Implications of Testing for Sexually Transmitted Infections in Children

M. Hammerschlag, Christina D. Guillén, 2010, Clinical Microbiology Reviews.

Chlamydia and Chlamydiales: beyond Chlamydia trachomatis.

M. Hammerschlag, 2007, The Pediatric infectious disease journal.

Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis.

M. Hammerschlag, M. Gelling, P. Roblin, 1997, The Pediatric infectious disease journal.

Treatment of neonatal chlamydial conjunctivitis with azithromycin.

M. Hammerschlag, M. Gelling, P. Roblin, 1998, The Pediatric infectious disease journal.

Chlamydia trachomatis as a Cause of Neonatal Conjunctivitis in Dutch Infants

H. Verbrugh, R. de Groot, M. Hammerschlag, 2008, Pediatrics.

Colonization of Sexually Abused Children with Genital Mycoplasmas

M. Hammerschlag, W. Mccormack, M. Cummings, 1987, Sexually transmitted diseases.

Nonspecific vaginitis following sexual abuse in children.

M. Hammerschlag, W. Mccormack, M. Cummings, 1985, Pediatrics.

The transmissibility of sexually transmitted diseases in sexually abused children.

M. Hammerschlag, 1998, Child abuse & neglect.

Sexually transmitted diseases in victims of sexual assault.

M. Hammerschlag, W. Mccormack, J. Glaser, 1986, The New England journal of medicine.

Are rectogenital chlamydial infections a marker of sexual abuse in children?

M. Hammerschlag, E. Alexander, P. Cox, 1984, Pediatric infectious disease.

STD in children: syphilis and gonorrhoea.

M. Hammerschlag, K. Bromberg, S. Rawstron, 1993, Genitourinary medicine.

False positive results with the use of chlamydial antigen detection tests in the evaluation of suspected sexual abuse in children

M. Hammerschlag, P. Rettig, M. Shields, 1988, The Pediatric infectious disease journal.

Anogenital Human Papillomavirus in Sexually Abused and Nonabused Children: A Multicenter Study

C. Beck-Sague, E. Unger, C. Black, 2011, Pediatrics.

Epidemiology of Sexually Transmitted Infections in Suspected Child Victims of Sexual Assault

C. Beck-Sague, E. Driebe, C. Black, 2009, Pediatrics.

Sexual assault and abuse of children.

M. Hammerschlag, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anaerobic microflora of the vagina in children.

J. Bartlett, A. Onderdonk, M. Hammerschlag, 1978, American journal of obstetrics and gynecology.

New Antimicrobial Agents for the Treatment of Staphylococcal Infections in Children.

M. Hammerschlag, Roopali Sharma, Densley Francois, 2017, Pediatric clinics of North America.

Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.

M. Hammerschlag, 1982, Reviews of infectious diseases.

In Vitro Activity of a Group of Broad-Spectrum Cephalosporins and Other β-Lactam Antibiotics Against Chlamydia trachomatis

M. Hammerschlag, A. Gleyzer, 1983, Antimicrobial Agents and Chemotherapy.

Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture.

M. Hammerschlag, J. Vuletin, 1985, The Journal of antimicrobial chemotherapy.

Ophthalmia Neonatorum Caused by β-Lactamase— Producing Neisseria gonorrhoeae

M. Hammerschlag, G. Pringle, B. Doraiswamy, 1983 .

Infectious causes of multiple sclerosis

G. Cutter, Roland Martin, G. Giovannoni, 2006, The Lancet Neurology.

Spontaneous Escherichia coli cellulitis in a child with nephrotic syndrome.

A. D'angelo, M. Hammerschlag, Joseph N Sleiman, 2007, The Pediatric infectious disease journal.

Draft Genome and Plasmid Sequences of Chlamydia pneumoniae Strain B21 from an Australian Endangered Marsupial, the Western Barred Bandicoot

P. Timms, S. Kohlhoff, A. Polkinghorne, 2014, Genome Announcements.

Multicenter Study of Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Children Being Evaluated for Sexual Abuse

C. Beck-Sague, E. Unger, E. Driebe, 2009, The Pediatric infectious disease journal.

Inappropriate Use of Nonculture Tests for the Detection of Chlamydia trachomatis in Suspected Victims of Child Sexual Abuse: A Continuing Problem

D. Laraque, M. Hammerschlag, Stephen Ajl, 1999, Pediatrics.

Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children.

C. Christian, A. Seña, K. Hsu, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians

P. Polgreen, D. Gilbert, J. Bennett, 2018, Open forum infectious diseases.

Chlamydia Trachomatis Infections and Pregnancy

M. Hammerschlag, 1987 .

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

J. Hedrick, S. Block, J. Craft, 1995, The Pediatric infectious disease journal.

Effect of Prolonged Treatment with Azithromycin, Clarithromycin, or Levofloxacin on Chlamydia pneumoniae in a Continuous-Infection Model

M. Hammerschlag, P. Roblin, A. Kutlin, 2002, Antimicrobial Agents and Chemotherapy.

Ophthalmia neonatorum caused by beta-lactamase-producing Neisseria gonorrhoeae.

M. Hammerschlag, G. Pringle, B. Doraiswamy, 1983, JAMA.

Update on Fusidic Acid (CEM-102) Tested against Neisseria gonorrhoeae and Chlamydia trachomatis

Ronald N. Jones, S. Kohlhoff, M. Hammerschlag, 2010, Antimicrobial Agents and Chemotherapy.

Development of PCR Assays for Detection of Trichomonas vaginalis in Urine Specimens

C. Black, J. Igietseme, C. Bandea, 2013, Journal of Clinical Microbiology.

Seroprevalence of Chlamydia trachomatis in Inner-City Children and Adolescents—Implications for Vaccine Development

J. Weedon, S. Kohlhoff, M. Hammerschlag, 2017, Sexually transmitted diseases.

Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2017, BMC Infectious Diseases.

Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women

M. Postma, H. Verbrugh, R. de Groot, 2016, Pathogens and global health.

Chlamydia trachomatis respiratory infection in Dutch infants

W. Hop, H. Verbrugh, R. de Groot, 2009, Archives of Disease in Childhood.

Guidelines for the use of molecular biological methods to detect sexually transmitted pathogens in cases of suspected sexual abuse in children.

C. Gaydos, M. Hammerschlag, 2012, Methods in molecular biology.

Azithromycin in the treatment of rectogenital Chlamydia trachomatis infections: end of an era?

M. Hammerschlag, Roopali Sharma, 2020, Expert review of anti-infective therapy.

Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection

M. Hammerschlag, W. Mccormack, L. Glass, 1993, The Pediatric infectious disease journal.

Antimicrobial susceptibility of Chlamydia spp

S. Kohlhoff, M. Hammerschlag, 2012 .

Infections in children due to Neisseria meningitidis serogroup 135.

R. Baltimore, M. Hammerschlag, 1978, Jornal de Pediatria.

Use of nucleic acid amplification tests in investigating child sexual abuse

M. Hammerschlag, 2001, Sexually transmitted infections.

Special article: Appropriate use of nonculture tests for the detection of sexually transmitted diseases in children and adolescents

M. Hammerschlag, 2003 .

Chlamydia pneumoniae-induced tumour necrosis factor alpha responses are lower in children with asthma compared with non-asthma

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2018, BMJ Open Respiratory Research.

In Vitro Activities of Rifamycin Derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, A. Kutlin, 2003, Antimicrobial Agents and Chemotherapy.

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, G. Montalban, 1994, Antimicrobial Agents and Chemotherapy.

In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.

M. Hammerschlag, P. Roblin, 2000, International journal of antimicrobial agents.

Asthmatic Children Have Increased Specific Anti–Mycoplasma pneumoniae IgM but not IgG or IgE—Values Independent of History of Respiratory Tract Infection

J. Silverberg, M. Bluth, S. Kohlhoff, 2013, The Pediatric infectious disease journal.

The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, 2004, The Journal of antimicrobial chemotherapy.

In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae

S. Kohlhoff, M. Hammerschlag, N. Huerta, 2019, Antimicrobial Agents and Chemotherapy.

Patterns of use of antibiotics in two newborn nurseries.

J. Klein, M. Hammerschlag, M Herschel, 1977, The New England journal of medicine.

In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

S. Kohlhoff, S. Hawser, M. Hammerschlag, 2004, Antimicrobial Agents and Chemotherapy.

Neonatal prophylaxis with antibiotic containing ointments does not reduce incidence of chlamydial conjunctivitis in newborns

S. Kohlhoff, T. Smith-Norowitz, M. Hammerschlag, 2021, BMC Infectious Diseases.

Diagnostic Practices for Suspected Community-Acquired Central Nervous System Infection in the Post-Conjugate Vaccine Era.

S. Kohlhoff, M. Hammerschlag, Natalie Banniettis, 2017, Pediatric emergency care.

In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.

M. Hammerschlag, P. Roblin, T. Reznik, 2003, International journal of antimicrobial agents.

Severe ocular reactions after neonatal ocular prophylaxis with gentamicin ophthalmic ointment.

H. Mendez, M. Hammerschlag, Rita Nathawad, 2011, The Pediatric infectious disease journal.

Comparison of two enzyme immunoassays to culture for the diagnosis of chlamydial conjunctivitis and respiratory infections in infants

M. Hammerschlag, M. Gelling, P. Roblin, 1987, Journal of clinical microbiology.

Perinatally Acquired Chlamydia trachomatis Infection in Children.

M. Hammerschlag, Natalie Banniettis, 2018, The Pediatric infectious disease journal.

Subclinical pneumonia in infants due to Chlamydia trachomatis.

M. Hammerschlag, 1981, The British journal of venereal diseases.

Chlamydial pneumonia: not for babies only?

M. Hammerschlag, 1981, JAMA.

Chlamydial pneumonia in infants.

M. Hammerschlag, 1978, The New England journal of medicine.

Comparison of enzyme immunoassay and culture for diagnosis of chlamydial conjunctivitis and respiratory infections in infants

L. Howard, M. Hammerschlag, P. Roblin, 1987, Journal of clinical microbiology.

Fluorescent antibody vs culture for detecting Chlamydia.

M. Hammerschlag, 1986, The Journal of pediatrics.

Chlamydia pneumoniae and asthma in children: diagnostic issues.

M. Hammerschlag, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chlamydial infections.

M. Hammerschlag, 1981, The Journal of pediatrics.

Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS

P. Sundström, M. Sandström, M. Hammerschlag, 2000, Neurology.

Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York

J. Silverberg, S. Kohlhoff, T. Smith-Norowitz, 2021, Human vaccines & immunotherapeutics.

Chlamydia trachomatis and Chlamydia pneumoniae Infections in Children and Adolescents

M. Hammerschlag, 2004, Pediatrics in review.

Hammerschlag Adolescents Chlamydia trachomatis and Chlamydia pneumoniae Infections in Children and

M. Hammerschlag, 2004 .

Olfactory dysfunction in children and adults post‐COVID‐19 infection in Brooklyn, New York

J. Silverberg, S. Kohlhoff, T. Smith-Norowitz, 2021, Acta paediatrica.

Head and neck infections in children due to Eikenella corrodens: Report of three cases and review of literature.

M. Hammerschlag, Caitlin Otto, Ashraf Abdelhemid, 2020, International journal of pediatric otorhinolaryngology.

West Nile virus: From epidemic to endemic

M. Hammerschlag, 2003 .

Colonization with Staphylococcus aureus in HIV-infected children and adolescents in Brooklyn, NY

H. Mendez, M. Hammerschlag, Rita Nathawad, 2012, Journal of Pediatric Infectious Diseases.

Failure of varicella‐zoster immunoglobulin in modification of severe congenital varicella

A. Gershon, M. Hammerschlag, S. Bakshi, 1986, Pediatric infectious disease.

Steady-state pharmacokinetics of oral linezolid suspension in a premature infant with osteomyelitis.

S. Kohlhoff, C. Peloquin, M. Hammerschlag, 2016, The Journal of antimicrobial chemotherapy.

Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate.

S. Kohlhoff, G. Valencia, M. Hammerschlag, 2007, International journal of antimicrobial agents.

New diagnostic methods for chlamydial infection in women.

M. Hammerschlag, 1999, Medscape women's health.

Scalp abscess associated with Mycoplasma hominis infection complicating intrapartum monitoring.

M. Hammerschlag, J. Glaser, M. Engelberg, 1983, Pediatric infectious disease.

Meningococcal osteomyelitis: a report of two cases associated with septic arthritis.

C. Baker, M. Hammerschlag, 1976, The Journal of pediatrics.

Universal Prenatal Screening and Testing and Chlamydia trachomatis Conjunctivitis in Infants.

S. Kohlhoff, M. Hammerschlag, Natalie Banniettis, 2020, Sexually transmitted diseases.

Caution Is Required When Using Non-Food and Drug Administration-Cleared Assays to Diagnose Sexually Transmitted Infections in Children.

R. Shapiro, M. Hammerschlag, Amanda D Brownell, 2019, The Journal of pediatrics.

Neonatal ocular prophylaxis in the United States: is it still necessary?

M. Hammerschlag, Susannah Franco, 2023, Expert review of anti-infective therapy.

Association of Routine Chlamydia trachomatis Screening During Pregnancy and Seroprevalence of Chlamydial Infection in Children, 1991-2015.

S. Kohlhoff, M. Hammerschlag, Natalie Banniettis, 2020, Journal of the Pediatric Infectious Diseases Society.

Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens.

M. Hammerschlag, C. Bébéar, M R Hammerschlag, 2001, The Journal of antimicrobial chemotherapy.

A longitudinal study of varicella immunity in pediatric renal transplant recipients.

H. Trachtman, A. Gershon, S. Steinberg, 1986, Journal of Infectious Diseases.

Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.

J. Ramirez, J. Summersgill, M. Hammerschlag, 2003, The Journal of antimicrobial chemotherapy.

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.

M. Hammerschlag, Roopali Sharma, 2008, Expert opinion on investigational drugs.

Molecular characterization of Chlamydophila pneumoniae isolates from Western barred bandicoots.

P. Timms, S. Kohlhoff, M. Hammerschlag, 2007, Journal of medical microbiology.

THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS

J. Ramirez, C. Stratton, J. Bartlett, 1997 .

Effect of Prolonged Treatment with Azithromycin, Clarithromycin, or Levofloxacin on Chlamydia pneumoniae in a Continuous-Infection Model

M. Hammerschlag, P. Roblin, A. Kutlin, 2002, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of a New Antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae

M. Hammerschlag, P. Roblin, 2003, Antimicrobial Agents and Chemotherapy.

Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis.

J. Bradley, M. Hammerschlag, B. Congeni, 1986, Pediatric infectious disease.

Update on Fusidic Acid (CEM-102) Tested against Neisseria gonorrhoeae and Chlamydia trachomatis

Ronald N. Jones, S. Kohlhoff, M. Hammerschlag, 2010, Antimicrobial Agents and Chemotherapy.

Inappropriate Use of Nonculture Tests for Detection of Chlamydia trachomatis in Suspected Victims of Child Sexual Abuse: A Continuing Problem

D. Laraque, M. Hammerschlag, Stephen Ajl, 1999, Pediatrics.

Clinical Practice: Acute Respiratory Infection Due to Chlamydia pneumoniae: Current Status of Diagnostic Methods

M. Hammerschlag, S. Kumar, 2007 .

In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae

S. Kohlhoff, M. Hammerschlag, P. Roblin, 2009, Antimicrobial Agents and Chemotherapy.